CN106728834A - A kind of medicine for treating asthma - Google Patents
A kind of medicine for treating asthma Download PDFInfo
- Publication number
- CN106728834A CN106728834A CN201611210190.5A CN201611210190A CN106728834A CN 106728834 A CN106728834 A CN 106728834A CN 201611210190 A CN201611210190 A CN 201611210190A CN 106728834 A CN106728834 A CN 106728834A
- Authority
- CN
- China
- Prior art keywords
- parts
- asthma
- medicine
- raw material
- effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
Abstract
The invention discloses a kind of medicine for treating asthma, belong to drug preparation technique field.It is made up of following raw material by weight：10~20 parts of Chinese yam, 10~20 parts of the tuber of dwarf lilyturf, 10~15 parts of Ligusticum wallichii, 6~12 parts of peach kernel, 6~12 parts of lily, 5~10 parts of gingko, 5~10 parts of matrimony vine, 8~15 parts of mulberry leaf, 8~15 parts of the fruit of Chinese magnoliavine, 2~6 parts of kelp base.The medicine of present invention treatment asthma, from natural Chinese medicinal herb as raw material, asthma is treated using the comprehensive function of each raw material components, toxic and side effect is small, and it is cheap, the effects such as with antitussive and antiasthmatic, anti-inflammation, relieving cough and reducing sputum, dispersing stagnated hepatoqi, antitoxic heart-soothing and sedative, the effect treated both principal and secondary aspect of disease can be reached, the out of breath, cough that occurs suitable for asthma patient, abundant expectoration, the symptom such as feel suffocated, also have significant curative effect to asthma for many years.
Description
Technical field
The invention belongs to drug preparation technique field, more particularly to a kind of medicine for treating asthma.
Background technology
Asthma also known as bronchial astehma, bronchial astehma are the chronic airway inflammations participated in by various kinds of cell and cellular component
Property disease, this chronic inflammation is related to airway hyperreactivity, generally occurs within extensive and changeable reversible airflow limitation, causes
The panting of recurrent exerbation, shortness of breath, it is uncomfortable in chest and（Or）The symptoms such as cough, more at night and（Or）Early morning breaking-out, aggravation.The hair of asthma
Cause of disease can be summarized as two kinds of extraneous factor and oneself factor because a lot.Patient's oneself factor includes the psychological condition of patient, exempts from
Epidemic disease state etc., also has relation with heredity.Asthma is hereditary disease, relevant with heredity allergic constitution, with nervous system and breathing
System cells inherent cause also has relation.In the extraneous factor that asthma causes, environmental factor is important induced factor.Allergy body
The people of matter, causes the state of an illness to be broken out under the influence of extraneous factor.As dust, breathing is easily infected containing bacterial micro-organism in dust
Road is so as to induce the breaking-out of asthma.Some chemical substances such as pungent such as sulfuric acid, ammonia can cause some Job people
Member's morbidity, in addition, the recurrent exerbation of respiratory infection diseases, also results in the breaking-out of the state of an illness.In the extraneous factor that asthma causes,
Common are human body nervous, system disorders in nerve can be caused, so as to induce the breaking-out of asthma, some foods can also cause
The breaking-out of the state of an illness, the food of human allergy is easily caused as fishes and shrimps etc..Long-term smoking can cause bronchial spasm, be also asthma hair
The major incentive of work.
At present, the Western medicine dependence for the treatment of asthma is big, costly, there is side effect, can have loss to liver kidney work(, takes stopgap measures not
Effect a permanent cure, Relapse rate recurrence, bad influence is caused on patients ' psychological sometimes.And middle the effective elements of the medicine is not easy to lose, side effect
It is small, Chinese medicinal formulae can because disease, because disease difference add and subtract at any time, and treatment diseases range it is wider.People are to effectively treatment asthma
There is great demand in Chinese medicine.
The content of the invention
It is an object of the invention to provide a kind of medicine for treating asthma, low cost, good effect, Small side effects.
The technical scheme is that：A kind of medicine for treating asthma, is made up of following raw material by weight：Chinese yam 10~
20 parts, 10~20 parts of the tuber of dwarf lilyturf, 10~15 parts of Ligusticum wallichii, 6~12 parts of peach kernel, 6~12 parts of lily, 5~10 parts of gingko, matrimony vine 5~10
Part, 8~15 parts of mulberry leaf, 8~15 parts of the fruit of Chinese magnoliavine, 2~6 parts of kelp base.
Further, it is made up of following raw material by weight：15~18 parts of Chinese yam, 15~18 parts of the tuber of dwarf lilyturf, Ligusticum wallichii 12~15
Part, 8~10 parts of peach kernel, 8~10 parts of lily, 6~8 parts of gingko, 6~8 parts of matrimony vine, 10~12 parts of mulberry leaf, 10~12 parts of the fruit of Chinese magnoliavine,
3~5 parts of kelp base.
Preferably, it is made up of following raw material by weight：15 parts of Chinese yam, 15 parts of the tuber of dwarf lilyturf, 10 parts of Ligusticum wallichii, 8 parts of peach kernel, lily
8 parts, 6 parts of gingko, 6 parts of matrimony vine, 10 parts of mulberry leaf, 10 parts of the fruit of Chinese magnoliavine, 3 parts of kelp base.
Wherein, the Main Function of above-mentioned medicinal raw material is：
Chinese yam：The effect of with invigorating spleen and reinforcing stomach, nourishing kidney and replenishing pneuma, benefit lung and restrain cough；Chinese yam contains saponin(e, lymphatic temperament, has lubrication, moistens
Effect, therefore can beneficial lung qi, support lung yin, treatment deficiency syndrome of the lung phlegm is coughed the disease of chronic cough；Modern medicine shows that the maximum feature of Chinese yam is to contain
There is substantial amounts of mucin, mucin is a kind of mixture of proteinpolysaccharide, has special health-care effect to human body, can be prevented
Fatty depositing keeps blood vessel elasticity on angiocarpy, prevents atherosclerosis from occurring to early.
The tuber of dwarf lilyturf：With moistening lung clears away heart-fire, purge heat and promote the production of body fluid, resolving sputum preventing or arresting vomiting, control the effect of coughing water-filling；Modern pharmacological research shows,
The tuber of dwarf lilyturf mainly glycosides containing dwarf lilyturf, steroid saponin, alkaloid, sitosterol, glucose, amino acid, vitamin etc., with it is antifatigue,
Remove free radical, improve cellular immune function and hypoglycemic effect；In addition, the tuber of dwarf lilyturf have calmness, hypnosis, resist myocardial ischemia,
Anti-arrhythmia, antitumor etc. are acted on, and especially have many-sided effect to promoting senior health and fitness.
Ligusticum wallichii：The effect of with blood-activating and qi-promoting, wind-expelling pain-stopping；Ligustrazine energy antagonism platelet aggregation contained in Ligusticum wallichii,
Suppress the release of inflammatory mediator, the bronchial smooth muscle that substantial amounts of ligustrazine medicinal extract can also release caused by acetylcholine shrinks,
Can be used to treat bronchial astehma.
Peach kernel：Dispelled with promoting blood circulation, the stasis of blood relaxes bowel, it is relieving cough and asthma the effect of；Modern medicine study thinks, the phosphorus in walnut
Fat, has excellent health functions to cranial nerve；Walnut oil contains unrighted acid, prevents and treats artery sclerosis.Walnut kernel
In contain the indispensable trace element of human body such as zinc, manganese, chromium；Human body zinc, manganese content in aging course are increasingly reduced, and chromium has
Promote glucose utilization, cholesterol metabolic and protect cardiovascular function；The antitussive and antiasthmatic of walnut kernel acts on also fairly obvious, the winter
Season, to chronic bronchitis and asthmatics' excellent curative.
Lily：The effect of with Yin nourishing and lung moistening, clearing away the heart fire and tranquillizing；Fresh lily bulb plays the role of calm cough-relieving, it is adaptable to bronchus
The edible for patients of the illnesss such as inflammation, pulmonary emphysema, hemoptysis of pulmonary tuberculosis.
Gingko：Relievingd asthma with astringing the lung, eliminating phlegm relieving asthma, inducing astrigency stop-band the effect of；Gingko kernel except containing starch, protein,
Outside fat, carbohydrate, also contain the trace element such as vitamin C, riboflavin, carrotene, calcium, phosphorus, iron, potassium, magnesium and ginkgo
The compositions such as acid, bilobol, five carbon polysaccharide, fat sterol, it is nutritious, and for beneficial lung qi, control cough and asthma, stop-band worm, reduce just,
Equalling the diseases such as chapped wrinkle, shield blood vessel, increase CBF, under band, gonorrhoea has good medical effect and dietary function.
Matrimony vine：With nourishing the liver moistening lung, qi-restoratives strengthening the essence, promote the production of body fluid to quench thirst, antipyretic cough-relieving the effect of；Modern medicine study thinks Chinese holly
Qi is improved immunity, anti-oxidant, anti-aging, fatigue-resisting function, and the fruit of Chinese wolfberry is rich in LBP-X, and LBP-X is a kind of water
Soluble polysaccharide, is made up of, with life arabinose, glucose, galactolipin, mannose, xylose, rhamnose this 6 kinds of monosaccharide components
Reason activity, can strengthen non-specific immune function, improve resistance against diseases, suppress tumour growth and cell mutation.
Mulberry leaf：With clearing away the lungheat and moisturizing, flat town cough-relieving, resolving sputum of reducing phlegm and internal heat, clear liver and improve vision the effect of；Modern medicine proves, mulberry leaf
First-class functional food, it can be depressured, lipid-loweringing, anti-aging, increase endurance, reduce cholesterol, suppress Fat Accumulation, suppress blood
Bolt generation, the oxide for suppressing intestinal toxic bacterial reproduction, suppressing to be harmful to are generated, and can treat anemopyretic cold, and lung-heat type cough is dizzy
Headache, the dim-sighted illness of hot eyes.
The fruit of Chinese magnoliavine：With astringe the lung to stop cough, nourish it is puckery essence, antidiarrheal hidroschesis the effect of, modern medicine study find the fruit of Chinese magnoliavine contain
There are abundant organic acid, vitamin, flavonoids, phytosterol and lignan, be that minority has essence, gas, the medicine of refreshing three big helps concurrently
One of material；The fruit of Chinese magnoliavine has excitation to nervous system maincenters at different levels, also has excitation to respiratory system, is entering body
The effect that eliminating the phlegm also has antibechic can be effectively played afterwards, in addition, additionally it is possible to effectively treat chronic bronchitis.
Kelp base：The effect of with clearing heat and eliminating phlegm, cough-relieving, soothing the liver, for controlling chronic bronchitis, cough, asthma is high
The symptoms such as blood pressure, dizziness.
The beneficial effects of the invention are as follows：The medicine of present invention treatment asthma, from natural Chinese medicinal herb as raw material, using each
The comprehensive function treatment asthma of raw material components, toxic and side effect is small and cheap, with antitussive and antiasthmatic, anti-inflammation, cough-relieving
The effects such as phlegm, dispersing stagnated hepatoqi, antitoxic heart-soothing and sedative, the effect treated both principal and secondary aspect of disease can be reached, it is adaptable to asthma patient occur it is out of breath, cough
Cough, abundant expectoration, the symptom such as feel suffocated, also have significant curative effect to asthma for many years.
Specific embodiment
Embodiment one
A kind of medicine for treating asthma, is made up of following raw material by weight：15 parts of Chinese yam, 15 parts of the tuber of dwarf lilyturf, 10 parts of Ligusticum wallichii, peach kernel
8 parts, 8 parts of lily, 6 parts of gingko, 6 parts of matrimony vine, 10 parts of mulberry leaf, 10 parts of the fruit of Chinese magnoliavine, 3 parts of kelp base.
Preparation method：Medicinal raw material is respectively crushed into fine powder by above-mentioned weight, is processed into by conventional pharmaceutical technique
Described tablet, powder, pill or capsule etc. in pharmacy；Or by pharmaceutical technologies such as traditional coarse crushing, immersion, heating extractions
It is made the oral liquid described in pharmacy.
Instructions of taking：Morning, noon and afternoon respectively take once, 15 days courses for the treatment of, avoid pungent, raw and cold thing.
150 asthmatic patients of selection, male 82, female 68, the age is minimum 24 years old, maximum 69 years old, the course of disease most short half a year, most
It is long 12 years.Diagnostic criteria：Reference《Tcm internal medicine Illnesses Diagnoses criterion of therapeutical effect》, i.e.,：Whistling sound in the throat when 1. breaking out, breathing is tired
Difficulty, very then opening mouth and lifting shoulder due to dyspnea, it is impossible to prostration, or the purple pincers of lip nail；2. be in repeated relapsing, often because abrupt change of climate, it is improper diet,
The factors such as disorder of emotion, fatigue induce, before breaking-out to have the tendency such as rhiocnesmus, sneeze, cough, uncomfortable in chest more；3. there are allergies or family
History；4. two lung audibles and wheezing sound, or with bubble；4. blood eosinophils can increase；5. the visible acidophilus of sputum smear
Cell；6. chest X-ray is general without special change, and the visible pulmonary emphysema of prolonged illness are levied.
Efficacy evaluation：Cure：Asthma control, wheezing sound disappears；Take a turn for the better：Stable asthma, or attack times are reduced；Do not heal：
Symptom is unchanged.
By clinical observation, symptom substantially mitigates after taking a course for the treatment of, and patient's SOA substantially slows down, and breathes unimpeded,
Spirit and QI cleaning symptom after 3~4 courses for the treatment of disappears, and respiratory system immunity strengthens and forms protective barrier, cough, expectoration, gas
Breathe heavily, shortness of breath, expiratory dyspnea are completely eliminated, vim and vigour running is unimpeded, recover pneumonocyte elasticity, improve the aerobic metabolizing ability of health,
Autoimmune antibody is produced, and the state of an illness is cured, and internal organs various functions recover normal.
Through clinical statisticses, cure 118, account for 78.7%；Take a turn for the better 26, account for 17.3%；Not more 6, account for 4%；Total effective rate is high
It is 96%, showing the medicine of present invention treatment asthma has good curative effect.
Typical case：
Case 1：Zhang, man 32 years old, the symptoms such as appearance, cough, expectoration, activity asthma was started before 2 years the year before lasts without obvious cause,
After taking 2 courses for the treatment of of medicine of present invention treatment asthma, symptom disappears, and is paid a return visit without recurrence after 1 year.
Case 2：Huang, female, 43 years old, panting occurred after catching a cold in 5 years causes flu, uncomfortable in chest, is broken out in paroxysmal, progressive
Aggravate, uncomfortable with cough, expectoration, palpitaition, expiratory dyspnea, nearest 1 year Relapse rate breaking-out, frequency increases, and degree is aggravated, and is caused
One's spirits are drooping, appetite and sleep degradation, after taking 3 courses for the treatment of of this medicine, symptom greatly slows down, and the state of mind improves, food
It is intended to and sleep quality is improved, after continuing to take 1 course for the treatment of, fully recovered, is paid a return visit without recurrence after 1 year.
Case 3：Multitude, man, 57 years old, be exactly usually shortness of breath uncomfortable in chest with bronchial astehma 10 years, always feels not breathing heavily
Gas, is from head to foot not energetically, with dizziness.When serious, often cough is panted very serious, is repeatedly sought medical advice and is taken medicine effect also not substantially,
Relapse rate is variable, and after 1 course for the treatment of of this medicine is taken, symptom substantially slows down, and continues to take after 3 courses for the treatment of, has approached and has fullyed recover from an illness
More, constitution has also strengthened, and is paid a return visit without recurrence after 1 year.
The above, specific embodiment only of the invention, but protection scope of the present invention is not limited thereto, and it is any
The change or simple replacement expected without creative work, should all be included within the scope of the present invention.
Claims (3)
1. a kind of medicine for treating asthma, it is characterised in that be made up of following raw material by weight：10~20 parts of Chinese yam, the tuber of dwarf lilyturf
10~20 parts, 10~15 parts of Ligusticum wallichii, 6~12 parts of peach kernel, 6~12 parts of lily, 5~10 parts of gingko, 5~10 parts of matrimony vine, mulberry leaf 8~
15 parts, 8~15 parts of the fruit of Chinese magnoliavine, 2~6 parts of kelp base.
2. the medicine of asthma is treated according to claim 1, it is characterised in that be made up of following raw material by weight：Chinese yam
15~18 parts, 15~18 parts of the tuber of dwarf lilyturf, 12~15 parts of Ligusticum wallichii, 8~10 parts of peach kernel, 8~10 parts of lily, 6~8 parts of gingko, matrimony vine 6~
8 parts, 10~12 parts of mulberry leaf, 10~12 parts of the fruit of Chinese magnoliavine, 3~5 parts of kelp base.
3. the medicine of asthma is treated according to claim 1, it is characterised in that be made up of following raw material by weight：Chinese yam
15 parts, 15 parts of the tuber of dwarf lilyturf, 10 parts of Ligusticum wallichii, 8 parts of peach kernel, 8 parts of lily, 6 parts of gingko, 6 parts of matrimony vine, 10 parts of mulberry leaf, 10 parts of the fruit of Chinese magnoliavine, sea
3 parts of root of band.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611210190.5A CN106728834A (en) | 2016-12-24 | 2016-12-24 | A kind of medicine for treating asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611210190.5A CN106728834A (en) | 2016-12-24 | 2016-12-24 | A kind of medicine for treating asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106728834A true CN106728834A (en) | 2017-05-31 |
Family
ID=58920448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611210190.5A Withdrawn CN106728834A (en) | 2016-12-24 | 2016-12-24 | A kind of medicine for treating asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106728834A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11679066B2 (en) | 2019-06-28 | 2023-06-20 | The Procter & Gamble Company | Dissolvable solid fibrous articles containing anionic surfactants |
-
2016
- 2016-12-24 CN CN201611210190.5A patent/CN106728834A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11679066B2 (en) | 2019-06-28 | 2023-06-20 | The Procter & Gamble Company | Dissolvable solid fibrous articles containing anionic surfactants |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102038048A (en) | Healthy tea for treating asthma cough and preparation method thereof | |
| CN102669366A (en) | Liver-protecting lung-moistening tea and preparation method thereof | |
| CN103719491B (en) | A kind of sealwort invigorating the spleen moistening lung health protection tea and preparation method thereof | |
| CN104663989A (en) | Soothing tea and preparation method thereof | |
| CN102552778B (en) | Medicinal composition for treating cough, and preparation method and application thereof | |
| CN103784638A (en) | Traditional Chinese medicine decoction used for preventing and treating children heat asthma | |
| CN104642678A (en) | Female beauty tranquilizing tea and preparation method thereof | |
| CN104306793B (en) | A kind of Chinese medicine preparation for treating lobar pneumonia | |
| CN106728834A (en) | A kind of medicine for treating asthma | |
| CN106139080A (en) | A kind of Chinese medicine preparation of hepatoprotective lung moistening and preparation method thereof | |
| CN104998080B (en) | A kind of Chinese medicine composition for being used to treat cough variant asthma | |
| CN100364587C (en) | Acupoint selection strapping medicine for treating chronic bronchitis and bronchial asthma and its compounding method | |
| CN101007153A (en) | Drug of gastrodia elata for caring brain | |
| CN1695704A (en) | Compound capsule for relieving cough | |
| CN102755507B (en) | A kind of traditional Chinese herbal decoction for the treatment of wind-dryness impariment of the lung type acute bronchitis | |
| CN100536889C (en) | Chinese-medicinal composition for treating bronchial asthma | |
| CN104399049A (en) | Traditional Chinese medicine mixture for treating cold type asthma | |
| CN103099877B (en) | Traditional Chinese medicine formula for treating and preventing children asthmatic disease | |
| CN102846924A (en) | Internal traditional Chinese medicine used for treating chronic bronchitis caused by phlegm-heat retention in lung | |
| CN103784534A (en) | Traditional Chinese medicine aerosol used for preventing and treating children heat asthma | |
| CN107582834A (en) | A kind of Chinese medicine composition for treating empty asthma | |
| CN101979065A (en) | Externally used Chinese medicinal liquor for treating eczema | |
| CN102688381B (en) | Traditional Chinese medicine decoction of fructus ligustri lucidi for treating cough and preparation method | |
| CN102755508B (en) | A kind of Chinese medicine decoction for the treatment of phlegm-heat accumulated in the lung type acute bronchitis | |
| CN107669887A (en) | A kind of medicine for improving Qi deficiency physique or health-care food composition and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170531 |
|
| WW01 | Invention patent application withdrawn after publication |